Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Rosas, H. D.
Feigin, A. S.
and
Hersch, Steven M.
2004.
Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington’s disease.
NeuroRX,
Vol. 1,
Issue. 2,
p.
263.
Reading, Sarah A. J.
Dziorny, Adam C.
Peroutka, Laura A.
Schreiber, Mathew
Gourley, Lisa M.
Yallapragada, Venu
Rosenblatt, Adam
Margolis, Russell L.
Pekar, James J.
Pearlson, Godfrey D.
Aylward, Elizabeth
Brandt, Jason
Bassett, Susan S.
and
Ross, Christopher A.
2004.
Functional brain changes in presymptomatic Huntington's disease.
Annals of Neurology,
Vol. 55,
Issue. 6,
p.
879.
Rosas, H. D.
Feigin, A. S.
and
Hersch, Steven M.
2004.
Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington’s disease.
NeuroRX,
Vol. 1,
Issue. 2,
p.
263.
Gohier, B.
Verny, C.
Bonneau, D.
Emeriaud, J.
Ricalens, E.
and
Garré, J.-B.
2005.
Place et rôle du psychiatre dans une consultation multidisciplinaire : l'exemple d'une consultation de neurogénétique.
Annales Médico-psychologiques, revue psychiatrique,
Vol. 163,
Issue. 8,
p.
697.
Reading, Sarah A.J.
Yassa, Michael A.
Bakker, Arnold
Dziorny, Adam C.
Gourley, Lisa M.
Yallapragada, Venu
Rosenblatt, Adam
Margolis, Russell L.
Aylward, Elizabeth H.
Brandt, Jason
Mori, Susumu
van Zijl, Peter
Bassett, Susan S.
and
Ross, Christopher A.
2005.
Regional white matter change in pre-symptomatic Huntington's disease: A diffusion tensor imaging study.
Psychiatry Research: Neuroimaging,
Vol. 140,
Issue. 1,
p.
55.
Rosas, H. Diana
Tuch, David S.
Hevelone, Nathanael D.
Zaleta, Alexandra K.
Vangel, Mark
Hersch, Steven M.
and
Salat, David H.
2006.
Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures.
Movement Disorders,
Vol. 21,
Issue. 9,
p.
1317.
Cooper, Douglas B.
Ales, Gregory
Lange, Christopher
and
Clement, Pamelia
2006.
Atypical Onset of Symptoms in Huntington Disease: Severe Cognitive Decline Preceding Chorea or Other Motor Manifestations.
Cognitive and Behavioral Neurology,
Vol. 19,
Issue. 4,
p.
222.
Pirogovsky, Eva
Gilbert, Paul E.
Jacobson, Mark
Peavy, Guerry
Wetter, Spencer
Goldstein, Jody
Corey-Bloom, Jody
and
Murphy, Claire
2007.
Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease.
Journal of Clinical and Experimental Neuropsychology,
Vol. 29,
Issue. 4,
p.
395.
Rosenblatt, Adam
2007.
Neuropsychiatry of Huntington's disease.
Dialogues in Clinical Neuroscience,
Vol. 9,
Issue. 2,
p.
191.
Verny, C.
Allain, P.
Prudean, A.
Malinge, M.‐C.
Gohier, B.
Scherer, C.
Bonneau, D.
Dubas, F.
and
Le Gall, D.
2007.
Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.
European Journal of Neurology,
Vol. 14,
Issue. 12,
p.
1344.
Silverstein, Steven M.
Berten, Sarah
Olson, Patricia
Paul, Robert
Williams, Leanne M.
Cooper, Nicholas
and
Gordon, Evian
2007.
Development and validation of a World-Wide-Web-based neurocognitive assessment battery: WebNeuro.
Behavior Research Methods,
Vol. 39,
Issue. 4,
p.
940.
Youssov, K.
and
Bachoud-Lévi, A.-C.
2008.
Malattia di Huntington: aspetti diagnostici attuali e applicazioni pratiche.
EMC - Neurologia,
Vol. 8,
Issue. 2,
p.
1.
Klöppel, Stefan
Draganski, Bogdan
Golding, Charlotte V.
Chu, Carlton
Nagy, Zoltan
Cook, Philip A.
Hicks, Stephen L.
Kennard, Christopher
Alexander, Daniel C.
Parker, Geoff J. M.
Tabrizi, Sarah J.
and
Frackowiak, Richard S. J.
2008.
White matter connections reflect changes in voluntary-guided saccades in pre-symptomatic Huntington's disease.
Brain,
Vol. 131,
Issue. 1,
p.
196.
Solomon, Andrea C.
Stout, Julie C.
Weaver, Marjorie
Queller, Sarah
Tomusk, Allison
Whitlock, Kathryn Burr
Hui, Siu L.
Marshall, Jeanine
Jackson, Jacqueline Gray
Siemers, Eric R.
Beristain, Xabier
Wojcieszek, Joanne
and
Foroud, Tatiana
2008.
Ten‐year rate of longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease.
Movement Disorders,
Vol. 23,
Issue. 13,
p.
1830.
Wolf, R.C.
Vasic, N.
Schönfeldt-Lecuona, C.
Ecker, D.
and
Landwehrmeyer, G.B.
2008.
Funktionelle Bildgebung kognitiver Prozesse bei M.-Huntington-Patienten und präsymptomatischen Mutationsträgern.
Der Nervenarzt,
Vol. 79,
Issue. 4,
p.
408.
Youssov, K.
and
Bachoud-Lévi, A.-C.
2008.
Maladie de Huntington : aspects diagnostiques actuels et applications pratiques.
EMC - Neurologie,
Vol. 5,
Issue. 1,
p.
1.
PIROGOVSKY, EVA
GOLDSTEIN, JODY
PEAVY, GUERRY
JACOBSON, MARK W.
COREY-BLOOM, JODY
and
GILBERT, PAUL E.
2009.
Temporal order memory deficits prior to clinical diagnosis in Huntington’s disease.
Journal of the International Neuropsychological Society,
Vol. 15,
Issue. 5,
p.
662.
Nguyen, Lan
Bradshaw, John L.
Stout, Julie C.
Croft, Rodney J.
and
Georgiou-Karistianis, Nellie
2010.
Electrophysiological measures as potential biomarkers in Huntington's disease: Review and future directions.
Brain Research Reviews,
Vol. 64,
Issue. 1,
p.
177.
van Walsem, Marleen R.
Sundet, Kjetil
Retterstøl, Lars
and
Sundseth, Øyvind
2010.
A double blind evaluation of cognitive decline in a Norwegian cohort of asymptomatic carriers of Huntington's disease.
Journal of Clinical and Experimental Neuropsychology,
Vol. 32,
Issue. 6,
p.
590.
O'Rourke, Justin J. F.
Beglinger, Leigh J.
Smith, Megan M.
Mills, James
Moser, David J.
Rowe, Kelly C.
Langbehn, Douglas R.
Duff, Kevin
Stout, Julie C.
Harrington, Deborah L.
Carlozzi, Noelle
Paulsen, Jane S.
and
the PREDICT-HD Investigators of the
2011.
The Trail Making Test in prodromal Huntington disease: Contributions of disease progression to test performance.
Journal of Clinical and Experimental Neuropsychology,
Vol. 33,
Issue. 5,
p.
567.